Nobuo Okumura

Prof. Nobuo Okumura

School of Health Sciences, Shinshu University

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MYMasahide Yazaki
Masahide Yazaki
TYTSUNEAKI YOSHINAGA
TSUNEAKI YOSHINAGA
YSYoshiki Sekijima
Yoshiki Sekijima
F亀Fuyuki 亀谷
Fuyuki 亀谷
NONobuo Okumura
Nobuo Okumura
Hereditary fibrinogen Aα-chain amyloidosis (Aα-chain amyloidosis) is a type of autosomal dominant systemic amyloidosis caused by mutations in fibrinogen Aα-chain gene (FGA). Patients with Aα-chain amyloidosis have been mainly reported in Western countries but have been rarely reported in Asia, with only five patients with Aα-chain amyloidosis being reported in Korea, China, and Japan. Clinically, the most prominent manifestation in Asian patients with Aα-chain amyloidosis is progressive nephropathy caused by excessive amyloid deposition in the glomeruli, which is similar to that observed in patients with Aα-chain amyloidosis in Western countries. In molecular features in Asian Aα-chain amyloidosis, the most common variant, E526V, was found in only one Chinese kindred, and other four kindred each had a different variant, which have not been identified in other countries. These variants are located in the C-terminal region (amino acid residues 517–555) of mature Aα-chain, which was similar to that observed in patients with Aα-chain amyloidosis in other countries. The precise number of Asian patients with Aα-chain amyloidosis is unclear. However, patients with Aα-chain amyloidosis do exist in Asian countries, and the majority of these patients may be diagnosed with other types of systemic amyloidosis.

24 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
YHYibing Han
Yibing Han
TTTakeshi Tomita
Takeshi Tomita
MKMasayoshi Kato
Masayoshi Kato
NANorihiro Ashihara
Norihiro Ashihara
YHYumiko Higuchi
Yumiko Higuchi
SHSachie Hiratsuka
Sachie Hiratsuka
Primary tumor cells metastasize to a distant preferred organ. However, the most decisive host factors that determine the precise locations of metastases in cancer patients remain unknown. We have demonstrated that post-translational citrullination of fibrinogen creates a metastatic niche in the vulnerable spots. Pulmonary endothelial cells mediate the citrullination of fibrinogen, changing its conformation, surface charge, and binding properties with serum amyloid A proteins (SAAs), to make it a host tissue-derived metastatic pathogen. The human-specific SAAs-citrullinated fibrinogen (CitFbg) complex recruits cancer cells to form a protein-metastatic cell aggregation in humanized SAA cluster mice. Furthermore, a CitFbg peptide works as a competitive inhibitor to block the homing of metastatic cells into the SAAs-CitFbg sites. The potential metastatic sites in the lungs of patients are clearly visualized by our specific antibody for CitFbg. Thus, CitFbg deposition displays metastatic risks for cancer patients, and the citrullinated peptide is a new type of metastasis inhibitor.

10 June 2014 in Thrombosis Research
Verified
Journal Article
Open access
PDF file
MIMinami Ikeda
Minami Ikeda
TKTamaki Kobayashi
Tamaki Kobayashi
SAShinpei Arai
Shinpei Arai
SMSaki Mukai
Saki Mukai
YTYuka Takezawa
Yuka Takezawa
NONobuo Okumura
Nobuo Okumura
We examined a 6-month-old girl with inherited fibrinogen abnormality and no history of bleeding or thrombosis. Routine coagulation screening tests showed a markedly low level of plasma fibrinogen determined by functional measurement and also a low level by antigenic measurement (functional/antigenic ratio = 0.295), suggesting hypodysfibrinogenemia. DNA sequence analysis was performed, and γT305A fibrinogen was synthesized in Chinese hamster ovary cells based on the results. We then functionally analyzed and compared with that of nearby recombinant γN308K fibrinogen. DNA sequence analysis revealed a heterozygous γT305A substitution (mature protein residue number). The γT305A fibrinogen indicated markedly impaired thrombin-catalyzed fibrin polymerization both in the presence or absence of 1 mM calcium ion compared with that of γN308K fibrinogen. Protection of plasmin degradation in the presence of calcium ion or Gly-Pro-Arg-Pro peptide (analogue for so-called knob ‘A’) and factor XIIIa-catalyzed fibrinogen crosslinking demonstrated that the calcium binding sites, hole ‘a’ and D:D interaction sites were all markedly impaired, whereas γN308Kwas impaired at the latter two sites. Molecular modeling demonstrated that γT305 is localized at a shorter distance than γN308 from the high affinity calcium binding site and hole ‘a’. Our findings suggest that γT305 might be important for construction of the overall structure of the γ module of fibrinogen. Substitution of γT305A leads to both dysfibrinogenemic and hypofibrinogenemic characterization, namely hypodysfibrinogenemia. We have already reported that recombinant γT305A fibrinogen was synthesized normally and secreted slightly, but was significantly reduced.

10 March 2004 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
SIS. Ishikawa
S. Ishikawa
MHM. Hirota‐Kawadobora
M. Hirota‐Kawadobora
MTM. Tozuka
M. Tozuka
KIK. Ishii
K. Ishii
FTF. Terasawa
F. Terasawa
NONobuo Okumura
Nobuo Okumura

1 October 2013 in Thrombosis Research
Verified
Journal Article
Open access
KSKeisuke Soya
Keisuke Soya
YTYuka Takezawa
Yuka Takezawa
NONobuo Okumura
Nobuo Okumura
FTFumiko Terasawa
Fumiko Terasawa
We report two novel hypofibrinogenemias, Shizuoka III and Kanazawa II, which are caused by heterozygous mutations in FGG. Shizuoka III showed c.147delT and 147_149insACA in FGG exon 3 and a subsequent frameshift mutation, resulting in mature protein γ23X (native protein: γ49X), and Kanazawa II showed c.1205G>A in FGG exon 9, resulting in γ376X (native protein: γ402X). To determine whether the truncated γ-chains, γ23X and γ376X, were synthesized and participated in the assembly of fibrinogen, mutant-type cDNA vectors were transfected into Chinese hamster ovary (CHO) cells. Significant levels of mutant fibrinogen were not detected by ELISA in the culture media and cell lysates. Immunoblot analysis of cell lysates revealed that the mutant γ-chain of γ376X was observed but intact fibrinogen was not. On the other hand, mutant γ-chain was not observed in γ23X-expressing cells. To demonstrate the involvement of the mechanisms of nonsense-mediated mRNA decay (NMD), we cloned wild- and mutant-type mini-genes containing γ23 or γ376 codon and transfected these into CHO cell lines in the absence or presence of cycloheximide as an NMD inhibitor. mRNA levels were determined using real-time quantitative RT-PCR in CHO cells. In the absence of cycloheximide, levels of mRNAs transcribed from the mutant gene were lower than from the wild-type gene whereas, in the presence of cycloheximide, levels of mRNAs transcribed from the mutant gene increased dose-dependently. Finally, these results demonstrated that mRNAs containing γ23X or γ376X are degraded by the NMD system and translation of the truncated γ-chain polypeptide decrease in patients' hepatocytes, resulting in hypofibrinogenemias.

3 August 2009 in Biochemistry
Verified
Journal Article
Open access
SBSheryl R. Bowley
Sheryl R. Bowley
NONobuo Okumura
Nobuo Okumura
SLSusan T. Lord
Susan T. Lord
“A:a” knob−hole interactions and D:D interfacial interactions are important for fibrin polymerization. Previous studies with recombinant γN308K fibrinogen, a substitution at the D:D interface, showed impaired polymerization. We examined the molecular basis for this loss of function by solving the crystal structure of γN308K fragment D. In contrast to previous fragment D crystals, the γN308K crystals belonged to a tetragonal space group with an unusually long unit cell (a = b = 95 Å, c = 448.3 Å). Alignment of the normal and γN308K structures showed the global structure of the variant was not changed and the knob “A” peptide GPRP was bound as usual to hole “a”. The substitution introduced an elongated positively charged patch in the D:D region. The structure showed novel, symmetric D:D crystal contacts between γN308K molecules, indicating the normal asymmetric D:D interface in fibrin would be unstable in this variant. We examined GPRP binding to γN308K in solution by plasmin protection assay. The results showed weaker peptide binding, suggesting that “A:a” interactions were altered. We examined fibrin network structures by scanning electron microscopy and found the variant fibers were thicker and more heterogeneous than normal fibers. Considered together, our structural and biochemical studies indicate both “A:a” and D:D interactions are weaker. We conclude that stable protofibrils cannot assemble from γN308K monomers, leading to impaired polymerization.